Immunome Inc. (IMNM) › RevenueImmunome Inc. (IMNM) — RevenueAnnual figures by fiscal year, from SEC filings.2023: $14.02M2024: $9.04M2025: $6.94M$6.94M2023Revenue (USD)2025Fiscal YearRevenueChange YoY2025$6.94M-23.2%2024$9.04M-35.5%2023$14.02M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share